Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Addressing a Market Gap: The Case for 'Make in India' Dialysis

Mint Mumbai

|

October 09, 2025

Chronic Kidney Disease (CKD) is rapidly emerging as a major public health challenge in India, imposing a significant economic burden on individuals and the healthcare system.

This growing epidemic is fuelled by the rising incidences of diabetes and hypertension—two primary risk factors for kidney disease.

The result is a ballooning number of patients who will eventually require dialysis, a lifesaving but costly procedure. This presents a critical challenge to the nation’s healthcare infrastructure, a problem compounded by significant market failure: India's heavy reliance on imported dialysis machines.

THE IMPORT DEPENDENCY TRAP

Currently, the vast majority of dialysis machines used in India are imported. This dependence creates several economic and logistical hurdles:

• High Capital Costs: Imported machines are expensive, making it financially challenging for hospitals, especially in Tier-2 and Tier-3 cities, to establish or expand dialysis centres.

FLERE HISTORIER FRA Mint Mumbai

Mint Mumbai

Europe bets on $25 bn space budget amid defence hike

Europe’s equivalent of NASA is seeking €22 billion ($25.

time to read

1 min

November 27, 2025

Mint Mumbai

Mint Mumbai

China’s ‘McNuggetization’: It’s beneficial for the environment

A wide-scope dietary shift in China is doing the planet a good turn

time to read

3 mins

November 27, 2025

Mint Mumbai

Flexi-cap funds in focus as smids falter

A silent pivot

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Labour codes: Focus on empathy and not just efficiency

The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.

time to read

3 mins

November 27, 2025

Mint Mumbai

These firms will sell shovels during semaglutide gold rush

Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.

time to read

2 mins

November 27, 2025

Mint Mumbai

HC to hear Apple's plea on fine in Dec

Apple is challenging the new penalty math formula in India's competition law.

time to read

1 min

November 27, 2025

Mint Mumbai

Climate crisis: Innovation works, compression doesn't

After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

MO Alternates launches its maiden private credit fund

The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions

time to read

3 mins

November 27, 2025

Mint Mumbai

Kharif grain production likely to rise to 173 mt

India's kharif foodgrain output is expected to rise to 173.

time to read

1 min

November 27, 2025

Mint Mumbai

IL&FS group repays ₹48,463 cr loan

Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.

time to read

1 min

November 27, 2025

Listen

Translate

Share

-
+

Change font size